Dashboard
Curated content

Companies
Funding rounds
Exits
Investors
Accelerators
Matching tool
Investment heatmap

News

Powered by

EIT Health
European Union
dealroom.co

Contact
FAQ
Privacy

Companies
Travere Therapeutics
Team
Team

Travere Therapeutics

Retrophin - Discovery and development of drugs to treat catastrophic diseases.

Launch date

2008

Employees

Market cap

€876m

Enterprise valuation

€945m (Public information from Sep 2024)

Share price

$15.06 TVTX

San Diego California (HQ)

http://retrophin.com

https://twitter.com/retrophin https://www.facebook.com/1558803391034818 https://www.linkedin.com/company/travererare/

B2B
manufacturing
health
biotechnology

hard tech
biotechnology
biotech and pharma
developer tools
neurology

Authorizing premium user...